Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
09 feb 2015 - 08:08
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug to Present at Drug Discovery USA 2015
Bericht
ECHEMINFO Conference on Advances in Drug Discovery and Design at Johns Hopkins, Baltimore, USA
HALLE/SAALE, Germany, 09 February 2015 - Probiodrug AG ("Probiodrug", Euronext: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, today announced that Mirko Buchholz, PhD, Senior Scientist Computational/Medicinal Chemistry at Probiodrug[1] has been invited to present at the Echeminfo Conference "Drug Discovery USA 2015 - Advances in Drug Discovery and Design" taking place at Johns Hopkins, from 9th to 11th February in Baltimore, USA.
Datum laatste update: 17 maart 2025